CTC
STXS icon

Central Trust Company’s Stereotaxis STXS Stock Holding History

Central Trust Company’s Portfolio STXS Stock Details STXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,000
Closed -$1.75K – 1413
2023
Q4 		$1.75K Buy
+1,000
New +$1.61K ﹤0.01% 1293

Other funds holding STXS

DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Central Trust Company's STXS Position: Q1 2024 in Review

Central Trust Company sold out of Stereotaxis (STXS) in Q1 2024, closing a stake of 1,000 shares — an estimated $1.75K sold.

Central Trust Company first reported a position in STXS in Q4 2023 and held it in 1 quarter. The position peaked at $1.75K in Q4 2023. 81 funds tracked by Wall St. Rank hold STXS as of Q1 2024.

  • Central Trust Company reported no remaining Stereotaxis position as of Q1 2024 after selling out during the quarter.
  • Central Trust Company sold 1,000 Stereotaxis shares in Q1 2024, an estimated $1.75K.
  • Central Trust Company first reported a position in Stereotaxis in Q4 2023 and held it in 1 quarter.
  • Central Trust Company's Stereotaxis position peaked at $1.75K in Q4 2023.
  • 81 funds tracked by Wall St. Rank held Stereotaxis as of Q1 2024.

Based on Central Trust Company's 13F filing for Q1 2024, filed 24 Apr 2024.